Significant changes have been introduced with the release of ISO 1856:2024, impacting testing strategies, risk assessments, and even regulatory compliance. Join Eurofins experts to learn critical insights into how these changes impact regulatory strategy and current devices, including regulatory implications for FDA submissions not completed by the July 5, 2026 deadline.
During this webinar you will learn: